Paper Details

  1. Home
  2. Paper Details

[Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].

Author: HoltkampM, KockelmannE, LendemansD, LoschF-P, McMurrayR

Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

This study discusses the use of eslicarbazepine acetate (ESL) as an add-on therapy for patients with partial-onset seizures (POS). The study highlights the favorable tolerability profile of ESL and its potential for improving seizure control.
Paper Details　
Original Abstract of the Article :
Due to inadequate seizure control achieved with antiepileptic drug (AED) monotherapy and the considerable side effects at high required doses, patients with partial-onset seizures (POS) often require AED combination therapy. Eslicarbazepine acetate (ESL) is licensed as an add-on therapy for POS and ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00115-016-0199-5

データ提供：米国国立医学図書館（NLM）

Eslicarbazepine Acetate: A Promising Add-on Therapy for Seizures

The management of [partial-onset seizures (POS)] often involves a combination of [antiepileptic drugs (AEDs)] due to the limitations of monotherapy. This study examines the effectiveness and tolerability of [eslicarbazepine acetate (ESL)] as an [add-on therapy] for [POS]. The researchers aimed to assess the efficacy of [ESL] in patients who had not achieved adequate seizure control with [AED monotherapy]. The results suggest that [ESL] demonstrates a favorable tolerability profile and may be a valuable option for patients with [POS] who require [AED combination therapy].

A New Path for Seizure Management

This research offers a promising new avenue for [POS] management, highlighting the potential of [eslicarbazepine acetate (ESL)] as an [add-on therapy] for patients who have not achieved adequate seizure control with [monotherapy]. The study's findings indicate that [ESL] may be a well-tolerated and effective treatment option for this challenging condition.

Living Well with Seizures

For those living with [seizures], staying informed about the latest treatment advancements and potential side effects is essential. Regular communication with your neurologist is crucial to ensure that you receive the most appropriate treatment for your specific needs. This research underscores the importance of exploring various treatment options to find the most effective and manageable approach for your condition.

Dr.Camel's Conclusion

Imagine a camel crossing a vast desert, encountering an unexpected oasis offering respite from the heat and thirst. This research provides a similar sense of relief for those struggling with [POS]. The study explores the potential of [eslicarbazepine acetate (ESL)] as a new source of relief, offering a refreshing path for those seeking better seizure management. However, like the ever-changing desert landscape, the search for effective treatments for [POS] continues, encouraging further exploration and advancements in this field.

Date :
  1. Date Completed 2017-03-20
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

27550387

DOI: Digital Object Identifier

10.1007/s00115-016-0199-5

Related Literature

Article Analysis
・Side Effects of eslicarbazepine
SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.